US Broker Ratings

Phathom Pharmaceuticals, Inc. (PHAT): Biotech’s Next Big Bet with a Projected 112% Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, has emerged as a focal point for investors seeking high-growth opportunities in the healthcare domain. With its focus..

Mereo BioPharma Group plc (MREO) Stock Analysis: A Biotech with 159.71% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) stands out in the biotechnology sector with an impressive potential upside of 159.71%, according to recent analyst ratings. This UK-based biopharmaceutical company is focused..

AMTD Digital Inc. (HKD) Stock Analysis: Is This Software Company’s 15.52% ROE Enough to Attract Investors?

AMTD Digital Inc. (NASDAQ: HKD), a notable player in the technology sector, has been intriguing investors with its distinctive business model that spans digital solutions, media services, and hospitality. Headquartered..

Absci Corporation (ABSI) Stock Report: Exploring the 222% Potential Upside in Biotech

Investors looking for promising opportunities in the biotechnology sector might want to take a closer look at Absci Corporation (NASDAQ: ABSI), a company that’s potentially poised for substantial growth. With..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Uncovering a Potential 136.83% Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) has captured investor attention with its innovative approach to minimally invasive brain surgery, offering a potential upside of 136.83% according to recent analyst ratings. As..

Sprout Social, Inc (SPT) Stock Analysis: A 30% Potential Upside Catches Investor Eyes

Sprout Social, Inc (NASDAQ: SPT) stands at an intriguing crossroads for investors, particularly those drawn to the technology sector’s dynamic nature. This Chicago-based company operates in the software application industry,..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Through the Stormy Seas of Revenue Decline

NetClass Technology Inc (NTCL), a burgeoning player in the technology sector, operates within the software application industry, providing innovative educational technology solutions across China and beyond. Despite its promising business..

Outset Medical (OM) Stock Analysis: Examining the 29% Potential Upside in the Healthcare Sector

Outset Medical, Inc. (OM), a prominent player in the healthcare sector focusing on innovative medical devices, has recently caught the attention of investors with its promising 29.14% potential upside. This..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unveiling a 77% Potential Upside in Biotechnology

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a key player in the biotechnology sector, is gaining attention with a potential upside of 77.21%. Based in South San Francisco, California, Rigel focuses on..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Strategic Opportunity with 28% Upside Potential

Nerdy Inc. (NRDY), a prominent player in the technology sector, is making waves with its innovative approach to online learning. With its headquarters nestled in Saint Louis, Missouri, Nerdy operates..

Viant Technology Inc. (DSP) Stock Analysis: Insights into a Potential 53% Upside for Tech Investors

Viant Technology Inc. (NASDAQ: DSP) has garnered significant attention in the tech investment community, and for good reason. With a market capitalization of $887.82 million, the company operates as a..

Cytek Biosciences (CTKB) Stock Analysis: 60% Potential Upside Amid Healthcare Innovations

Cytek Biosciences, Inc. (NASDAQ: CTKB) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $453.44 million, this Fremont, California-based..

Grab Holdings Limited (GRAB) Stock Analysis: Strong Buy Ratings and 16% Potential Upside

Grab Holdings Limited (GRAB), a dominant player in the Southeast Asian “superapp” space, continues to capture investor attention with its diverse service offerings across mobility, deliveries, and digital financial services...

Pacific Biosciences of California (PACB) Stock Analysis: Is the 38.85% Potential Upside Worth the Risk?

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a prominent player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Menlo Park, California, is known..

Alpha Tau Medical Ltd. (DRTS): Investor Outlook Reveals 168% Potential Upside with Promising Oncology Innovations

Alpha Tau Medical Ltd. (NASDAQ: DRTS), headquartered in Jerusalem, Israel, is carving a niche in the healthcare sector with its innovative approach to oncology therapeutics. Focused on the biotechnology industry,..

Marti Technologies, Inc. (MRT) Stock Analysis: A Look at the 78% Upside Potential

Marti Technologies, Inc. (NASDAQ: MRT) is attracting attention in the investment community, driven by its innovative approach to urban transportation in Turkey and an enticing 78% potential upside according to..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Unveiling a Potential 382% Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is capturing the attention of investors with its innovative approach in the biotechnology sector. With a current..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Biotech Innovator Positioned for Growth Amidst Clinical Advances

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is gaining traction in the biotechnology sector with its innovative approach to targeting genetically defined diseases. This clinical-stage biopharmaceutical company, headquartered in the biotech hub..

Aurora Cannabis Inc. (ACB): Investor Outlook Highlights Revenue Growth and Analyst Ratings

Aurora Cannabis Inc. (ACB), a prominent player in the healthcare sector, specializes in the production, distribution, and sale of cannabis and cannabis-derivative products. With its headquarters in Edmonton, Canada, Aurora..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 355% Upside Potential

For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings (NASDAQ: ARCT) presents an intriguing opportunity. With a market capitalization of $401.11 million, this San Diego-based biotech..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds